Featured Videos

On the second day of the AACR meeting, Jonathan Grinstein, PhD, senior editor at GEN joined Julianna LeMieux, PhD, GEN’s deputy editor in chief, to chat about how they spent their day. Grinstein describes his excitement surrounding cancer vaccines while LeMieux shares some takeaways from the Expo Hall and spotlight theaters including Revvity and genomics companies such as Canopy Biosciences, Akoya Biosciences, Alamar Biosciences, Singular Genomics, and SomaLogic.

A Video Update from Day Two of the AACR Meeting

The American Association for Cancer Research (AACR) meeting is off and running in San Diego, California. Julianna LeMieux, PhD, Deputy Editor in Chief and Jonathan Grinstein, PhD, Senior Editor at GEN are on the ground—in the talks, expo hall, and press room, covering as much of the news as they can.
Here, they take a moment to chat about the first day at the meeting, with a focus on the opening plenary session featuring Aviv Regev from Genentech, Jakob Nikolas Kather, from Technical University Dresden, Ben Cravatt, Scripps Research, and Carolyn Bertozzi, Stanford University.

AACR 2024: A Video Update from San Diego

The State of Omics 2024

In this 4-hour GEN event--The State of Omics--leaders from the world of genome technology, analysis, NGS and multiomics offer a pulsating view of the rapid progress in this field. They will present on and discuss the arrival and application of groundbreaking new technologies that place the human genome into a richer biological context than ever before and offer a pulsating view of the rapid progress in this field.
March 2024 issue of GEN

Dancers look insane if you cannot hear the music. And yet the dancers we know as biomolecules usually get the benefit of the doubt, even if the steps they take, the ensembles they join, and the tempos they keep follow a logic that we cannot quite grasp. Usually, biomolecules perform as they should, sustaining our health, our very lives. Sometimes, however, biomolecules disturb life’s delicate choreography, giving rise to disease. To discover how this might happen—and devise remedies—we can take a close look at protein-protein interactions. Several ways of doing so are suggested by this month’s cover story. Other stories in this issue could benefit from dance metaphors. For example, we see how bioconjugates may consist of unusual partners, how spatial omics may suffer if the scientific dance becomes a legal dance, and how the music of the market energizes or depresses scientific careers. And we can see that cancer genomics and synthetic biology are getting ready to break some moves, too.